Home | Publications | Country | Latin America | Cuba place holder
place holder place holder

Cuba

The Pharmaceutical Market: Cuba


Publication Date   February 2007
Publisher   Espicom
Product Type   Strategic Report
Pages   88
ISBN Number   not applicable
Product Code   ESP601
Ask a question about this product?

Price £595.00

approximately: $1,194 | €747

Summary


Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

Cuba is one of the world's last unreconstructed communist countries. Ruled since the 1950s by Dr Fidel Castro, Cuba has attempted none of the economic reforms implemented in eastern Europe or even China. Despite this, the country has a reputation for the quality of its health services and health indicators, and has an impressive pharmaceutical/biotechnology research sector. This reputation is deserved in part, but conceals an ageing healthcare system in dire need of restructuring and modernising, none of which can be achieved without greatly increased funding.

During the Cold War, Cuba was a major Soviet ally, and the market remained largely closed to the West. During the 1990s, however, many countries in the West established links with Cuba. The USA, virtually alone, maintains its embargo against Cuba. This is starting to hurt US healthcare firms, as companies based in Asia, Canada and Western Europe have the high-tech market to themselves. The international healthcare industry is taking an increasing interest in Cuba, which in turn has made efforts to integrate into the global marketplace in an attempt to attract new funding for its healthcare system.

Since its realignment under the consortium QUIMEFA in 2001, domestic pharmaceutical production has kept growing, with increasing biotechnology export opportunities not only in developing countries but also in Europe and other developed countries. Cuba maintains a list of essential medicines (CBM), with 827 in 2005, of which 521 are domestically produced. There is no commercial advertising in Cuba, instead advertising has an educational purpose. Cuba affords some level of pharmaceutical patent protection, although less than international norms. Since 2001, FARMACUBA has acted as importer, exporter and distributor for QUIMEFA.

Content


Background Data

  • Geography
  • Political Overview
  • Economic Overview
    • Estimated/Projected GDP (PPP), 2004 - 2012
  • Population
    • Population, 1990-2005
    • Population by Province and Age Group, 2005
    • Population by Age Group, 2000-2005 (%)
  • Demographic Indicators
    • Principal Demographic Indicators, 1996-2005
  • Mortality
    • Selected Causes of Death, 2002-05
    • Selected Causes of Death as % of Total, 2002-05
    • Rate/000 of Selected Causes of Death, 2002-05
    • Causes of Death, 2005
    • Infant Mortality
    • Infant Deaths by Selected Cause, 2000-2005
  • Morbidity
    • Incidence of Infectious Disease, 1999-2005
    • Cancer Incidence
    • Cancer Incidence by Site, Males, 1998-2002
    • Cancer Incidence by Site, Females, 1998-2002
  • Charts
    • Map of Cuba
    • CUBA

Healthcare System

    • Chichester, West Sussex, PO20 2FS, United Kingdom
  • Organisation & Administration
  • Health Expenditure
    • Estimated Health Expenditure, 2001-2005 (US$ Billion)
    • Estimated Health Expenditure as % of GDP, 2001-2005
    • Public Health Expenditure, 1990-2005
  • Hospital Services
    • Hospital Resources
    • Hospitals by Province, 1998-2005
    • Hospitals by Type, 2005
    • Hospital Beds by Province, 2000-2005
    • Hospital Beds by Category, 2000-2005
    • Intensive care units
    • Hospital Activity
    • Hospital Admissions, 1990-2005
    • ALOS, 2000-2005 (Days)
    • Bed Occupancy, 2000-2005 (%)
    • Surgical Procedures
    • Operations Performed, 2000-2005
  • Ambulatory Care
    • Outpatient Facilities, 2001-2005
    • Medical/Dental Patient Consultations, 1990-2005
    • Medical Consultations by Sector, 2005
    • Medical Consultations by Sector, 2004
    • Civilian Medical Consultations by Therapeutic Area, 2000-2005
  • Medical Personnel
    • Physicians & Dentists, 1994-2005
    • Physicians & Dentists by Province, 2005
    • Physicians by Specialty, 2001-2005
    • Nursing Staff
    • Nursing Staff by Province, 2001-05
    • CUBA HEALTHCARE SYSTEM
  • Charts
    • Hospital Beds, 1990-2005
    • Hospital Admissions & Operations Performed, 1990-2005
    • CUBA

Accessing The Pharmaceutical Market

    • Chichester, West Sussex, PO20 2FS, United Kingdom
  • Introduction
  • Regulatory Environment
    • Pharmaceutical Registration/ Drug Approval Process
    • Registration of Antiretrovirals
    • Registered Antiretrovirals, 2000-2003
    • Advertising
    • Patent Protection & Intellectual Property Rights
    • Pricing & Reimbursement
  • Distribution Channels
    • Distributors
  • Farmacuba
    • Leading Pharmaceutical Product Lines Distributed by FARMACUBA, 2004
  • Trade Fairs
    • Salud para Todos
    • US-Cuba Healthcare Exhibition
  • Domestic Production
    • Pharmaceutical Production, 1997-2005 (Million Pesos)
    • List of Essential Medicines (CBM) by Sector & Origin, 2005
    • List of Essential Medicines (CBM) by Origin, 2005 (%)
    • Trade Associations
  • Quimefa
    • Domestic Producers
    • Leading Domestic Producers in Havana, 2003
    • Adalberto Pessant
  • Cidem
    • CIGB (Heber Biotec)
    • CIGB's Product Lines, 2004
    • CIM (CIMAB)
    • Eron
    • Instituto FINLAY
  • Medilip
  • Medsol
    • Reynaldo Gutirrez
    • Roberto Escudero Daz
    • 8 de Marzo
    • Foreign Producers
    • CUBA ACCESSING THE PHARMACEUTICAL MARKET
    • CancerVax
    • Genesis Medical Technologies
    • GlaxoSmithKline
    • Research & Development
    • Clinical Trials
    • Clinical Trial Authorisations and Modifications by Product Type, Cumulative 2002
    • Applicants for Clinical Trial Authorisations, Cumulative 2002
    • Clinical Trial Authorisations by Institution, 2001-2003
  • Directory
    • Government Organisations
    • Trade Associations
  • Charts
    • Drug Registrations, 1990-2003
    • Community Pharmacies, 1995-2004
    • Pharmaceutical Production, 1997-2005 (Million Pesos)